Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Liver international (Print)

• Publication date

  2015-05-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/liv.12592PMID 24836705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinase‐10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair

  2014cited by this paper
• Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension.

  2014cited by this paper
• Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection.

  2013cited by this paper
• Prognostic factors and prevention of radioembolization‐induced liver disease

  2013cited by this paper
• Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice

  2013cited by this paper
• Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma.

  2013influential reference
• Volumetric Changes after 90Y Radioembolization for Hepatocellular Carcinoma in Cirrhosis: An Option to Portal Vein Embolization in a Preoperative Setting?

  2013cited by this paper
• Liver regeneration.

  2012cited by this paper
• Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study

  2012cited by this paper
• Hepatic Toxicity After Radioembolization of the Liver Using 90Y-Microspheres: Sequential Lobar Versus Whole Liver Approach

  2012cited by this paper
• Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas.

  2010cited by this paper
• Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization

  2009cited by this paper
• Liver Regeneration and the Atrophy-Hypertrophy Complex

  2008cited by this paper
• Fibrosis, Portal Hypertension, and Hepatic Volume Changes Induced by Intra-arterial Radiotherapy with 90Yttrium Microspheres

  2008cited by this paper
• Liver disease induced by radioembolization of liver tumors

  2008influential reference
• Mechanisms of Hepatic Regeneration Following Portal Vein Embolization and Partial Hepatectomy: A Review

  2007cited by this paper
• Metalloproteinase inhibitor TIMP‐1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration

  2005cited by this paper
• Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome

  2003cited by this paper
• Serum proinflammatory cytokine response in patients with advanced liver tumors following selective internal radiation therapy (SIRT) with (90)Yttrium microspheres.

  2001cited by this paper
• Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study

  2000cited by this paper
• Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study

  1998cited by this paper
• Liver Regeneration

  1997cited by this paper
• Serum levels of cytokines after bone marrow transplantation: increased IL‐8 levels during severe veno‐occlusive disease of the liver

  1997influential reference
• Extracellular matrix remodeling at the early stages of liver regeneration in the rat

  1997cited by this paper
• Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: The role of glutathione and relevance to hepatic venoocclusive disease

  1996cited by this paper
• Biphasic changes in serum hepatocyte growth factor after transarterial chemoembolization therapy for hepato-cellular carcinoma.

  1996cited by this paper
• Hepatic toxicity resulting from cancer treatment.

  1995influential reference
• Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers.

  1991cited by this paper
• Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules.

  1987cited by this paper
• Pathogenesis of veno-occlusive liver disease after radiation.

  1980cited by this paper

• Fully automated spleen segmentation predicts progression-free survival in HCC patients following transarterial radioembolization.

  2026cites this paper
• Yttrium-90 downstages giant hepatocellular carcinoma to resectable size.

  2026cites this paper
• TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer

  2025cites this paper
• Liver protection of CACA technical guidelines for holistic integrative management of cancer

  2025cites this paper
• Combination locoregional and systemic therapies in hepatocellular carcinoma.

  2025cites this paper
• Novel Treatment of Yttrium‐90 Radioembolization‐Induced Liver Disease With Defibrotide in a Pediatric Liver Transplant Recipient

  2025cites this paper
• Combination therapy strategy based on selective internal radiation therapy as conversion therapy for inoperable giant hepatocellular carcinoma: A case report

  2025cites this paper
• Anatomical Quantitative Volumetric Evaluation of Liver Segments in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy: Key Parameters Influencing Untreated Liver Hypertrophy

  2024cites this paper
• Impact of IL-8 on survival after TARE in HCC: a comprehensive investigation and external validation from the SORAMIC trial

  2024cites this paper
• Modified Radiation Lobectomy Strategy of Radioembolization for Right-Sided Unresectable Primary Liver Tumors.

  2024cites this paper
• Immune Effects of Intra-Arterial Liver-Directed Therapies.

  2024cites this paper
• Immune checkpoint inhibition: a future guided by radiology

  2023cites this paper
• The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma

  2023cites this paper
• D-dimer for assessment of treatment response, and survival to drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma.

  2023cites this paper
• Cancer Immunology: Impact of Radioembolization of Heptocellular Carcinoma on Immune Response Modulation.

  2023cites this paper
• Selective internal radiation therapy with yttrium‐90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma

  2023cites this paper
• A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits

  2022cites this paper
• Radioembolization-Induced Changes in Hepatic [18F]FDG Metabolism in Non-Tumorous Liver Parenchyma

  2022cites this paper
• The Radiation Dose Absorbed by Healthy Parenchyma Is a Predictor for the Rate of Contralateral Hypertrophy After Unilobar Radioembolization of the Right Liver

  2022cites this paper
• Radiological and pathological assessment with EOB-MRI after Y90 radiation lobectomy prior to liver resection for hepatocellular carcinoma.

  2022cites this paper
• SIRT in 2025

  2022cites this paper
• Immunotherapy-Based Treatments of Hepatocellular Carcinoma: AJR Expert Panel Narrative Review.

  2022cites this paper
• Pure laparoscopic major liver resection after yttrium90 radioembolization: a case-matched series analysis of feasibility and outcomes

  2022cites this paper
• Facteurs prédictifs de la toxicité hépatique de la radio-embolisation par microsphères marquées à l’Yttrium-90 dans les hépatocarcinomes

  2022cites this paper
• 1 Pre-treatment sTNFR1 and HGF levels predict toxicity and overall survival after 90 Y radioembolization: potential novel application of biomarkers for personalized management of hepatotoxicity

  2021cites this paper
• Induction of contralateral hepatic hypertrophy by unilobar 90Y transarterial radioembolization vs. portal vein embolization: an animal study.

  2021cites this paper
• Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study

  2021cites this paper
• Hepatobiliary Scintigraphy and Glass 90Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver

  2021cites this paper
• Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization

  2021cites this paper
• Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy

  2021cites this paper
• Radiation Segmentectomy

  2021cites this paper
• Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma.

  2021cites this paper
• Transarterial Radioembolization in Hepatocellular Carcinoma

  2021cites this paper
• The importance of liver functional reserve in the non-surgical treatment of Hepatocellular Carcinoma.

  2021cites this paper
• Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC

  2021cites this paper
• Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity

  2021cites this paper
• The evolution of interventional oncology in the 21st century.

  2020cites this paper
• The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT

  2020cites this paper
• Combination Therapies with Y90: Immunoradiation

  2020cites this paper
• Increasing Yttrium-90 Dose Conformality Using Proximal Radioembolization Enabled by Distal Angiosomal Truncation for the Treatment of Hepatic Malignancy.

  2020cites this paper
• Chemorefractory liver metastasis from cervical cancer successfully treated with a combination of yttrium-90 and immunotherapy

  2020cites this paper
• PET/CT Imaging Characteristics After Radioembolization of Hepatic Metastasis from Breast Cancer

  2019cites this paper
• Combined locoregional-immunotherapy for liver cancer.

  2019cites this paper
• Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma

  2019cites this paper
• Hepatocellular Carcinoma: Essentials Interventional Radiologists Need to Know

  2019cites this paper
• Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.

  2019cites this paper
• Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma.

  2019cites this paper
• Yttrium-90 Radioembolization After Local Hepatic Therapy: How Prior Treatments Impact Patient Selection, Dosing, and Toxicity.

  2019cites this paper
• Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy

  2018cites this paper
• „Auf den Punkt gebracht“ − Die Radioembolisation primärer und sekundärer Lebertumoren mit unterschiedlichen Mikrosphären

  2018cites this paper
• Kinetic analysis of contralateral liver hypertrophy after radioembolization of primary and metastatic liver tumors

  2018cites this paper
• Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma

  2017cites this paper
• Radioembolization-induced liver disease: a systematic review

  2017cites this paper
• Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.

  2017cites this paper
• Cytokines and 90Y-Radioembolization: Relation to Liver Function and Overall Survival

  2017influential citation
• Prevention and treatment of complications of selective internal radiation therapy: Expert guidance and systematic review

  2017cites this paper
• Stem Cell Therapeutics of Acute Liver Diseases, Transplantation, andRegeneration

  2017cites this paper
• Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization.

  2016cites this paper
• Tumor-Specific D-Dimer Concentration Ranges and Influencing Factors: A Cross-Sectional Study

  2016cites this paper
• Kontralaterale Leberhypertrophie nach einseitiger Yttrium-90-Radioembolisation

  2016cites this paper
• 90Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments

  2015cites this paper
• Radioembolization as an adjunct therapy to the resection of liver tumors.

  2015cites this paper
• Hepatic Radioembolization : An Update on Current Practice and Recent Developments

  2015cites this paper
• Histological Changes in Nontumoral Liver Secondary to Radioembolization of Hepatocellular Carcinoma with Yttrium 90-impregnated Microspheres: Report of Two Cases

  2014cites this paper
• Chemoembolization and radioembolization.

  2014cites this paper
• World Journal of Radiology

  year unknowncites this paper